XMTR Stock Analysis: Xometry | NASDAQ

Industrial Distribution | NASDAQ, USA | Market Cap: 4.864m USD | 12M Return: 82.1% | US98423F1093 | Charts, Fundamentals & Technical Analysis

CNC Machining, 3D Printing, Injection Molding, Sheet Fabrication
Total Rating 56
Safety 83
Buy Signal 1.30
Industrial Distribution
Industry Rotation: +3.5
Market Cap: 4.86B
Avg Turnover: 44.4M
Risk 3d forecast
Volatility75.1%
VaR 5th Pctl11.8%
VaR vs Median-3.72%
Reward TTM
Sharpe Ratio1.07
Rel. Str. IBD95.2
Rel. Str. Peer Group95.5
Character TTM
Beta2.307
Beta Downside1.509
Hurst Exponent0.492
Drawdowns 3y
Max DD70.44%
CAGR/Max DD1.11
CAGR/Mean DD2.99
EPS (Earnings per Share) EPS (Earnings per Share) of XMTR over the last years for every Quarter: "2021-09": -0.33, "2021-12": -0.4, "2022-03": -0.27, "2022-06": -0.18, "2022-09": -0.11, "2022-12": -0.29, "2023-03": -0.2, "2023-06": -0.14, "2023-09": -0.05, "2023-12": -0.01, "2024-03": -0.12, "2024-06": -0.01, "2024-09": 0.02, "2024-12": 0.06, "2025-03": 0.02, "2025-06": 0.09, "2025-09": 0.11, "2025-12": 0.16, "2026-03": 0.12, "2026-06": -0.05,
Last SUE: 0.74
Qual. Beats: 0
Revenue Revenue of XMTR over the last years for every Quarter: 2021-09: 56.727, 2021-12: 67.098, 2022-03: 83.671, 2022-06: 95.615, 2022-09: 103.571, 2022-12: 98.196, 2023-03: 105.326, 2023-06: 111.008, 2023-09: 118.927, 2023-12: 128.145, 2024-03: 122.69, 2024-06: 132.595, 2024-09: 141.698, 2024-12: 148.546, 2025-03: 150.971, 2025-06: 162.547, 2025-09: 180.715, 2025-12: 192.398, 2026-03: 205.138, 2026-06: 229.28,
Rev. CAGR: 23.80%
Rev. Trend: 99.3%
Last SUE: 2.73
Qual. Beats: 6

Warnings

High Debt/EBITDA With Thin Interest Coverage
High Debt While Negative Cash Flow
Interest Coverage Ratio Critical

Tailwinds

Rs Leader
Idiosyncratic Leader
Avwap Ph Week

Seasonality 5.1 years of data

Jan -4.3% 21
Feb -23.6% 51
Mar -7.4% 47
Apr +8.2% 22
May +25.7% 25
Jun -0.2% 9
Jul -3.7% 10
Aug +40.8% 32
Sep +3.5% 22
Oct -0.8% 0
Nov +36.4% 24
Dec +17.5% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: XMTR Xometry

Xometry, Inc. (NASDAQ: XMTR) operates an AI-powered online manufacturing marketplace that connects buyers with suppliers of custom-manufactured parts and assemblies, serving customers in the United States and internationally. The platform provides instant pricing and lead times through its proprietary quoting engine, and includes the Thomasnet industrial sourcing platform, which functions as an online directory of industrial suppliers, products, and services.

Beyond its core marketplace, Xometry offers cloud-based solutions such as Workcenter (a financial and manufacturing execution system) and Teamspace (a collaboration tool), alongside direct manufacturing capabilities including CNC machining, injection molding, 3D printing, sheet cutting, die casting, urethane casting, and tube bending and cutting, as well as finishing, rapid prototyping, and production services.

The company serves a diverse range of end markets, including aerospace, industrial, medical devices, automotive, consumer goods, defense, government, energy, education, and robotics. Xometry was incorporated in 2013, originally as NextLine Manufacturing Corp., and is headquartered in North Bethesda, Maryland. The company is classified within the Industrials sector and the Trading Companies & Distributors sub-industry, reflecting its two-sided marketplace business model in which it aggregates demand and matches it with a distributed network of manufacturing suppliers rather than primarily producing parts itself.

Headlines to Watch Out For
  • AI marketplace active buyer growth accelerates transaction volume
  • Thomasnet integration expands supplier base and digital marketing revenue
  • Path to adjusted EBITDA profitability hinges on gross margin expansion
Piotroski VR-10 (Strict) 1.5
Net Income: -30.8m TTM > 0 and > 6% of Revenue
FCF/TA: -0.01 > 0.02 and ΔFCF/TA 1.67 > 1.0
NWC/Revenue: 57.36% < 20% (prev 40.49%; Δ 16.87% < -1%)
CFO/TA 0.03 > 3% & CFO 27.7m > Net Income -30.8m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 3.21 > 1.5 & < 3
Outstanding Shares: last quarter (53.1m) vs 12m ago 5.06% < -2%
Gross Margin: 38.75% > 18% (prev 39.15%; Δ -0.40% > 0.5%)
Asset Turnover: 92.56% > 50% (prev 87.88%; Δ 4.68% > 0%)
Interest Coverage Ratio: -6.23 > 6 (EBIT TTM -30.6m / Interest Expense TTM 4.91m)
Altman Z'' 2.63
A: 0.44 (Total Current Assets 672.4m - Total Current Liabilities 209.2m) / Total Assets 1.06b
B: -0.42 (Retained Earnings -442.6m / Total Assets 1.06b)
C: -0.04 (EBIT TTM -30.6m / Avg Total Assets 872.4m)
D: 1.29 (Book Value of Equity 595.0m / Total Liabilities 461.6m)
Altman-Z'' = 2.63 = A
Beneish M -2.90
DSRI: 1.12 (Receivables 130.3m/86.9m, Revenue 807.5m/603.8m)
GMI: 1.01 (GM 39.15% / 38.75%)
AQI: 0.64 (AQ_t 0.28 / AQ_t-1 0.44)
SGI: 1.34 (Revenue 807.5m / 603.8m)
TATA: -0.06 (NI -30.8m - CFO 27.7m) / TA 1.06b)
Beneish M = -2.90 (Cap -4..+1) = A
What is the price of XMTR shares?

As of September 18, 2026, the stock is trading at USD 93.15 with a total of 957,135 shares traded. Over the past week, the price has changed by +8.83%, over one month by +3.81%, over three months by +8.34% and over the past year by +82.08%.

Current recommended Stop Loss: 87.20 (which is 6.4% or 1.4 ATR below the current price).

Is XMTR a buy, sell or hold?

Xometry has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy XMTR.

  • StrongBuy: 4
  • Buy: 3
  • Hold: 2
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the XMTR price?
Analysts Target Price 110.3 18.4%
Xometry (XMTR) - Fundamental Data Overview as of 12 September 2026
Market Cap USD = 4.86b (4.86b USD * 1.0 USD.USD)
P/E Forward = 76.9231
P/S = 6.0232
P/B = 8.2427
Revenue TTM = 807.5m USD
EBIT TTM = -30.6m USD
EBITDA TTM = -9.81m USD
Long Term Debt = 243.2m USD (from longTermDebt, last quarter)
Short Term Debt = 88.0m USD (from shortTermDebt, last quarter)
Debt = 350.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.1m
Net Debt = -165.8m USD (calculated: Debt 350.9m - CCE 516.7m)
Enterprise Value = 4.70b USD (4.86b + Debt 350.9m - CCE 516.7m)
Interest Coverage Ratio = -6.23 (Ebit TTM -30.6m / Interest Expense TTM 4.91m)
EV/FCF = -336.8x (Enterprise Value 4.70b / FCF TTM -13.9m)
FCF Yield = -0.30% (FCF TTM -13.9m / Enterprise Value 4.70b)
FCF Margin = -1.73% (FCF TTM -13.9m / Revenue TTM 807.5m)
Net Margin = -3.82% (Net Income TTM -30.8m / Revenue TTM 807.5m)
Gross Margin = 38.75% ((Revenue TTM 807.5m - Cost of Revenue TTM 494.6m) / Revenue TTM)
Gross Margin QoQ = 38.01% (prev 38.26%)
Tobins Q-Ratio = 4.44 (Enterprise Value 4.70b / Total Assets 1.06b)
Interest Expense / Debt = 1.40% (Interest Expense 4.91m / Debt 350.9m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -24.2m (EBIT -30.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.21 (Total Current Assets 672.4m / Total Current Liabilities 209.2m)
Debt / Equity = 0.59 (Debt 350.9m / totalStockholderEquity, last quarter 595.0m)
 Debt / EBITDA = 16.90 (negative EBITDA) (Net Debt -165.8m / EBITDA -9.81m)
 Debt / FCF = 11.88 (negative FCF - burning cash) (Net Debt -165.8m / FCF TTM -13.9m)
 Total Stockholder Equity = 356.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.53% (Net Income -30.8m / Total Assets 1.06b)
RoE = -8.65% (Net Income TTM -30.8m / Total Stockholder Equity 356.2m)
RoCE = -5.10% (EBIT -30.6m / Capital Employed (Equity 356.2m + L.T.Debt 243.2m))
 RoIC = -2.70% (negative operating profit) (NOPAT -24.2m / Invested Capital 896.2m)
 WACC = 13.23% (E(4.86b)/V(5.21b) * Re(14.10%) + D(350.9m)/V(5.21b) * Rd(1.40%) * (1-Tc(0.21)))
Discount Rate = 14.10% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 96.97 | Cagr: 4.01%
 [DCF] Fair Price = unknown (Cash Flow -13.9m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.74 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 23.80% | SUE: 2.73 | # QB: 6
EPS current Quarter (2026-09-30): EPS=0.19 | Chg30d=+1.53% | Revisions=-44% | Analysts=10
EPS current Year (2026-12-31): EPS=0.70 | Chg30d=+0.54% | Revisions=-10% | GrowthEPS=+84.7% | GrowthRev=+33.7%
EPS next Year (2027-12-31): EPS=1.29 | Chg30d=+0.51% | Revisions=-38% | GrowthEPS=+83.5% | GrowthRev=+21.6%
[Analyst] Revisions Ratio: -38% (up=5, down=13)